NCT05110677

Brief Summary

The aim of this explorative pilot study is to present muscle perfusion of the lower extremity in patients with PAD using the Multispectral Optoacoustic Tomography (MSOT) method to build a 3D reconstruction of the calf muscle. This study aims to show the feasibility of 3D reconstruction of this non-invasive method. Advantages in diagnostics for patients with PAD and three-dimensional tomography representation of the perfusion situation based on muscle oxygenation will be evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
9

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

November 8, 2021

Completed
16 days until next milestone

Study Start

First participant enrolled

November 24, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
Last Updated

February 21, 2022

Status Verified

February 1, 2022

Enrollment Period

2 months

First QC Date

October 12, 2021

Last Update Submit

February 18, 2022

Conditions

Keywords

Peripheral Vascular DiseasePeripheral Arterial DiseaseMultispectral Optoacoustic TomographyMSOTPADClaudicatio intermittensCritical Limb IschemiaCLIDiagnostic imagingColor-Coded Duplex SonographyCCDSNon-invasive diagnostic procedurenon-invasive diagnosticnoninvasive diagnostic3D imagingthree-dimensional imagingthree-dimensional diagnostic3D diagnostictattoo tomographyoptical pattern

Outcome Measures

Primary Outcomes (1)

  • MSOT topogram showing MSOT parameters from 660 up to 1100 nm of the gastrocnemius muscle

    MSOT topogram using 3D reconstruction based on longitudinal 2D scans trough an optical pattern showing MSOT parameters from 660 up to 1100 nm of the gastrocnemius muscle

    single time point (1 day)

Secondary Outcomes (10)

  • Acquisition of the quantitative hemoglobin signal (oxygenated/deoxygenated)

    single time point (1 day)

  • Acquisition of the quantitative fibrosis signals (collagen/lipid)

    single time point (1 day)

  • 3D reconstruction of the longitudinal measurements using two different pattern designs

    single time point (1 day)

  • Acquisition of static 2D MSOT measurements before and after gait exposure

    single time point (1 day)

  • Validation of the accuracy of the MSOT 3D reconstruction using an overlay from MRA

    single time point (1 day)

  • +5 more secondary outcomes

Study Arms (1)

Study group

Multispectral Optoacoustic Tomography (MSOT) and B-Mode Ultrasound of the Musculus gastrocnemius of the affected leg in PAD patients or one leg in healthy volunteers (total 1 site) Physical assessment: Color-Coded Duplex Sonography/treadmill examination to determine actual walking distance/Ankle-Brachial-Index/defined walking distance of 150 meters under medical supervision

Device: Multispectral Optoacoustic Tomography (MSOT)

Interventions

non-invasive transcutaneous imaging of subcellular muscle components

Study group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with PAD IIa/IIb/III/IV according to Fontaine who come in for a routine presentation of the the vascular surgery consultation hours. Healthy volunteers with * no PAD previously known * no diabetes mellitus previously known * no chronic renal insufficiency previously known * no symptoms in the sense of a Claudicatio intermittens * ABI with normal value who are recruited by clinic notices.

You may qualify if:

  • Patients with manifest PAD stages II-IV according to Fontaine or healthy volunteers
  • Adult (\>18 years) persons who are able to give their consent

You may not qualify if:

  • Patients with PAD stage I according to Fontaine
  • Healthy volunteers with pre-existing diabetes mellitus, chronic renal failure, or abnormal ABI
  • Underage persons
  • Missing consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Erlangen, Vascular Surgery

Erlangen, 91054, Germany

Location

Related Publications (3)

  • Signorelli SS, Vanella L, Abraham NG, Scuto S, Marino E, Rocic P. Pathophysiology of chronic peripheral ischemia: new perspectives. Ther Adv Chronic Dis. 2020 Feb 5;11:2040622319894466. doi: 10.1177/2040622319894466. eCollection 2020.

    PMID: 32076496BACKGROUND
  • Karlas A, Kallmayer M, Fasoula NA, Liapis E, Bariotakis M, Kronke M, Anastasopoulou M, Reber J, Eckstein HH, Ntziachristos V. Multispectral optoacoustic tomography of muscle perfusion and oxygenation under arterial and venous occlusion: A human pilot study. J Biophotonics. 2020 Jun;13(6):e201960169. doi: 10.1002/jbio.201960169. Epub 2020 Mar 25.

    PMID: 32134550BACKGROUND
  • Holzwarth N, Schellenberg M, Grohl J, Dreher K, Nolke JH, Seitel A, Tizabi MD, Muller-Stich BP, Maier-Hein L. Tattoo tomography: Freehand 3D photoacoustic image reconstruction with an optical pattern. Int J Comput Assist Radiol Surg. 2021 Jul;16(7):1101-1110. doi: 10.1007/s11548-021-02399-w. Epub 2021 May 16.

    PMID: 33993409BACKGROUND

MeSH Terms

Conditions

Peripheral Vascular DiseasesPeripheral Arterial DiseaseChronic Limb-Threatening Ischemia

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesAtherosclerosisArteriosclerosisArterial Occlusive DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsIschemia

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PD Dr. med.

Study Record Dates

First Submitted

October 12, 2021

First Posted

November 8, 2021

Study Start

November 24, 2021

Primary Completion

January 31, 2022

Study Completion

July 31, 2022

Last Updated

February 21, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations